Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2026-02-22 @ 9:04 AM
Study NCT ID:
NCT06724835
Status:
RECRUITING
Last Update Posted:
2024-12-09
First Post:
2024-12-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)
Sponsor:
Shenzhen Celconta Life Science Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2023YP31H01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None